Back

Quality of life measures with etripamil self-administration for acute episodes of paroxysmal supraventricular tachycardia in a medically unsupervised setting: patient-reported outcomes from NODE-303

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Novel diagnostic approaches and treatments for supraventricular tachycardias Treatment ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor John Camm

City St George's University of London, London (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
The occurrence of atrioventricular nodal reentrant tachycardia requires not only the electrophysiological substrate but also the electro-anatomical characteristics in the triangle of Koch
Associate Professor T. Mine (Nishinomiya, JP)
Abstract Slides Video
Presentation thumbnail
Impact of the underlying rhythm during cavotricuspid isthmus ablation on the incidence of future new-onset atrial fibrillation: insights from an international multi-centre registry
Doctor J. Katic (Split, HR)
Abstract Slides Video
Presentation thumbnail
Participation of epicardial connection in transverse conduction across the crista terminalis in patients with upper and lower loop reentry atrial tachycardias
Mr T. Ishihara (Gifu, JP)
Abstract Slides Video
Presentation thumbnail
Collision mapping enables accurate localization of the slow pathway in atrioventricular nodal reentrant tachycardia
Associate Professor T. Seewoester (Leipzig, DE)
Abstract Slides Video
Presentation thumbnail
Novel approach of slow pathway ablation in common atrioventricular nodal reentrant tachycardia by peak frequency map
Doctor M. Takahashi (Tokyo, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Novel diagnostic approaches and treatments for supraventricular tachycardias

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Randomized, double-blind, placebo-controlled, efficacy and safety study of etripamil self-administration for the termination of episodes of paroxysmal supraventricular tachycardia in chinese patients
thumbnail
Congress Presentation
Impact of ablate and pace on clinical outcomes, quality of life and healthcare utilization in patients with atrial fibrillation
thumbnail
Congress Presentation
Quality of life after screening for atrial fibrillation: a substudy from a randomised screening trial

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources